Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Results from the I-PRESERVE Trial

Autor Haass, Markus, Kitzman, Dalane W., Anand, Inder S., Miller, Alan, Zile, Michael R., Massie, Barry M., Carson, Peter E.
Vydáno 2011

Characterization of Subgroups of Heart Failure Patients with Preserved Ejection Fraction with Possible Implications for Prognosis and Treatment Response

Autor Kao, David P, Lewsey, James D, Anand, Inder S, Massie, Barry M, Zile, Michael, Carson, Peter E, McKelvie, Robert, Komajda, Michel, McMurray, John, Lindenfeld, JoAnn
Vydáno v Eur J Heart Fail (2015)

Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction: The Irbesartan in Heart Failure With Preserved Ejec...

Autor Lam, Carolyn S.P., Carson, Peter E., Anand, Inder S., Rector, Thomas S., Kuskowski, Michael, Komajda, Michel, McKelvie, Robert S., McMurray, John J., Zile, Michael R., Massie, Barry M., Kitzman, Dalane W.
Vydáno v Circ Heart Fail (2012)

Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction

Autor Shen, Li, Jhund, Pardeep S., Anand, Inder S., Carson, Peter E., Desai, Akshay S., Granger, Christopher B., Køber, Lars, Komajda, Michel, McKelvie, Robert S., Pfeffer, Marc A., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J. V.
Vydáno v Clin Res Cardiol (2020)

Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation

Autor Kao, David P., Davis, Gordon, Aleong, Ryan, O'Connor, Christopher M., Fiuzat, Mona, Carson, Peter E., Anand, Inder S., Plehn, Jonathan F., Gottlieb, Stephen S., Silver, Marc A., Lindenfeld, JoAnn, Miller, Alan B., White, Michel, Murphy, Guinevere A., Sauer, Will, Bristow, Michael R.
Vydáno 2013

Burden of Medical Comorbidities and Benefit from Surgical Revascularization in Patients with Ischemic Cardiomyopathy

Autor Ambrosy, Andrew P., Stevens, Susanna R., Al-Khalidi, Hussein R., Rouleau, Jean L., Bouabdallaoui, Nadia, Carson, Peter E., Adlbrecht, Christopher, Cleland, John G.F., Dabrowski, Rafal, Golba, Krzysztof S., Pina, Ileana L., Sueta, Carla A., Roy, Ambuj, Sopko, George, Bonow, Robert O., Velazquez, Eric J.
Vydáno v Eur J Heart Fail (2019)

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials

Autor Abdul-Rahim, Azmil H., Perez, Ana-Cristina, MacIsaac, Rachael L., Jhund, Pardeep S., Claggett, Brian L., Carson, Peter E., Komajda, Michel, McKelvie, Robert S., Zile, Michael R., Swedberg, Karl, Yusuf, Salim, Pfeffer, Marc A., Solomon, Scott D., Lip, Gregory Y.H., Lees, Kennedy R., McMurray, John J.V.
Vydáno v Eur Heart J (2017)

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction

Autor Shen, Li, Rørth, Rasmus, Cosmi, Deborah, Kristensen, Søren Lund, Petrie, Mark C., Cosmi, Franco, Latini, Roberto, Køber, Lars, Anand, Inder S., Carson, Peter E., Granger, Christopher B., Komajda, Michel, McKelvie, Robert S., Solomon, Scott D., Staszewsky, Lidia, Swedberg, Karl, Huynh, Thao, Zile, Michael R., Jhund, Pardeep S., McMurray, John J.V.
Vydáno v Eur J Heart Fail (2019)

Combinatorial Pharmacogenetic Interactions of Bucindolol and β(1), α(2C) Adrenergic Receptor Polymorphisms

Autor O'Connor, Christopher M., Fiuzat, Mona, Carson, Peter E., Anand, Inder S., Plehn, Jonathan F., Gottlieb, Stephen S., Silver, Marc A., Lindenfeld, JoAnn, Miller, Alan B., White, Michel, Walsh, Ryan, Nelson, Penny, Medway, Allen, Davis, Gordon, Robertson, Alastair D., Port, J. David, Carr, James, Murphy, Guinevere A., Lazzeroni, Laura C., Abraham, William T., Liggett, Stephen B., Bristow, Michael R.
Vydáno 2012

Heart Failure Endpoints in Cardiovascular Outcome Trials of SGLT2 inhibitors in Patients with Type 2 Diabetes: A Critical Evaluation of Clinical and Regulatory Issues

Autor Butler, Javed, Packer, Milton, Greene, Stephen J., Fiuzat, Mona, Anker, Stefan D., Anstrom, Kevin J., Carson, Peter E., Cooper, Lauren B., Fonarow, Gregg C., Hernandez, Adrian F., Januzzi, James L., Jessup, Mariell, Kalyani, Rita R., Kaul, Sanjay, Kosiborod, Mikhail, Lindenfeld, JoAnn, McGuire, Darren K., Sabatine, Marc S., Solomon, Scott D., Teerlink, John R., Vaduganathan, Muthiah, Yancy, Clyde W., Stockbridge, Norman, O’Connor, Christopher M.
Vydáno v Circulation (2019)

Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel

Autor Psotka, Mitchell A., Abraham, William T., Fiuzat, Mona, Filippatos, Gerasimos, Lindenfeld, JoAnn, Ahmad, Tariq, Bhatt, Ankeet S., Carson, Peter E., Cleland, John G.F., Felker, G. Michael, Januzzi, James L., Kitzman, Dalane W., Leifer, Eric S., Lewis, Eldrin F., McMurray, John J.V., Mentz, Robert J., Solomon, Scott D., Stockbridge, Norman, Teerlink, John R., Vaduganathan, Muthiah, Vardeny, Orly, Whellan, David J., Wittes, Janet, Anker, Stefan D., O'Connor, Christopher M.
Vydáno v J Am Coll Cardiol (2020)